Last reviewed · How we verify

NCT03080753

Treatment of Anal Incontinence With Intersphincteric Implants

Terminated NA Last updated 1 March 2024
What this trial tests

NA trial testing Sphinkeeper in Anal Incontinence in 10 participants. Terminated before completion.

Timeline
11 October 2017
Primary endpoint
1 October 2019
1 October 2019

Quick facts

Lead sponsorRegion Skane
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date11 October 2017
Primary completion1 October 2019
Estimated completion1 October 2019
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Anal Incontinence or Fecal Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether treatment with intersphincteric implants is an effective and safe treatment option for patients with anal incontinence

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical effectiveness and safety of self-expandable implantable bulking agents for faecal incontinence: a systematic review.
    Gassner L, Wild C, Walter M. · · 2022 · cited 5× · PMID 35978293 · DOI 10.1186/s12876-022-02441-4

Verify or expand the search:

Other recruiting trials for Anal Incontinence

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03080753.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing